The combination of GM-CSF-secreting tumor cell vaccines and anti-CTLA-4 antibody was also demonstrated to increase the ratio of tumor-infiltrating CD8+ cytotoxic T cells to Tregs in preclinical and clinical studies [35]. This evidence concerns the gene CTLA4 and neoplasm.